Mark Lupher
Direttore/Membro del Consiglio presso ADVERUM BIOTECHNOLOGIES, INC.
Patrimonio netto: 122 070 $ in data 30/04/2024
Profilo
Mark L.
Lupher is the founder and president of VeritasRx Consulting, which is founded in 2013.
He is currently an independent director at Adverum Biotechnologies, Inc. since 2019.
Dr. Lupher's former positions include being a principal at Immunex Corp., ICOS Corp., and a VP-Translational Pharmacology at Sutro Biopharma, Inc. He was also the Chief Scientific Officer at Promedior, Inc. from 2010 to 2013.
Dr. Lupher is a member of The Brigham & Women's Hospital, Inc. Dr. Lupher received his doctorate from Harvard University in 1998 and his undergraduate degree from the University of Washington in 1994.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 22/04/2024 | 13 000 ( 0.06% ) | 122 070 $ | 30/04/2024 |
Posizioni attive di Mark Lupher
| Società | Posizione | Inizio |
|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Direttore/Membro del Consiglio | 01/05/2019 |
| VeritasRx Consulting | Fondatore | 01/01/2013 |
Precedenti posizioni note di Mark Lupher
| Società | Posizione | Fine |
|---|---|---|
| SUTRO BIOPHARMA, INC. | Corporate Officer/Principal | 01/03/2020 |
Promedior, Inc.
 Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | Direttore Tecnico/Scientifico/R&S | 01/06/2013 |
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Corporate Officer/Principal | 01/02/2007 |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Corporate Officer/Principal | - |
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Formazione di Mark Lupher
| Harvard University | Doctorate Degree |
| University of Washington | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SUTRO BIOPHARMA, INC. | Health Technology |
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Health Technology |
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Health Technology |
The Brigham & Women's Hospital, Inc.
The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Health Services |
Promedior, Inc.
Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | Health Technology |
| VeritasRx Consulting |
- Borsa valori
- Insiders
- Mark Lupher